20 June 2013
Keywords: sandoz, gene, therapy, brain, cancer, efficacy, trial
Article | 07 October 1996
- An efficacy trial of gene therapy in brain cancer patients has
been initiated by Sandoz Pharmaceuticals. The therapy, GLI-328, is ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 October 1996
19 June 2013
© 2013 thepharmaletter.com